Retatrutide – 10mg (3 Pack)

Retatrutide is a novel triple-agonist peptide that targets GLP-1, GIP,
and glucagon receptors simultaneously. This unique activity has made it a key
compound in research on metabolic disorders, obesity, and insulin sensitivity.
The 3 pack of 10mg vials offers a bundled format for extended laboratory studies
requiring multiple units.

Potential Research Benefits

• Studied for weight reduction and appetite regulation
• Explored for insulin sensitivity & glucose control
• Supports energy expenditure & lipid metabolism studies
• Triple receptor engagement: GLP-1, GIP & glucagon

Scientific Background

Unlike single- and dual-agonist peptides, Retatrutide’s triple-agonist mechanism
provides broader metabolic engagement. Research indicates this may enhance weight loss,
glucose regulation, and lipid control in experimental settings.
The inclusion of glucagon receptor activity distinguishes it from
other incretin-based compounds and makes it a focus of next-generation research.

Product Details

• Compound: Retatrutide
• Form: Lyophilized Powder
• Amount: 10mg per vial
• Pack Size: 3 vials (10mg each)
• Total Peptide: 30mg
• Purity: ≥99%
• Appearance: White to off-white powder
• Research Use Only: Not for human consumption